WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Ownership - Who owns Rhythm Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rhythm Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pamela J. CramerChief Human Resources Officer2025-07-291,520$85.93
$130.61kSell
Christopher Paul GermanCorporate Controller CAO2025-07-092,000$17.97
$35.94kBuy
Hunter C. SmithChief Financial Officer2025-07-0917,113$75.38
$1.29MSell
Hunter C. SmithChief Financial Officer2025-07-0942,120$6.88
$289.79kBuy
Hunter C. SmithChief Financial Officer2025-07-0923,400$84.50
$1.98MSell
Hunter C. SmithChief Financial Officer2025-07-091,607$76.17
$122.41kSell
Joseph ShulmanChief Technical Officer2025-07-097,969$6.80
$54.19kBuy
Joseph ShulmanChief Technical Officer2025-07-093,984$75.57
$301.05kSell
Joseph ShulmanChief Technical Officer2025-07-093,985$80.00
$318.80kSell
Christopher Paul GermanCorporate Controller CAO2025-07-091,850$85.00
$157.25kSell

1 of 13

RYTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RYTM insiders and whales buy or sell their stock.

RYTM Shareholders

What type of owners hold Rhythm Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.77%6,854,755$586.97MInstitution
Ra Capital Management LP9.56%6,084,412$521.01MInstitution
Primecap Management Co9.10%5,787,322$495.57MInstitution
Baker Bros Advisors LP8.81%5,604,483$479.91MInstitution
Ra Capital Management LP6.85%4,360,860$373.42MInsider
Vanguard Group Inc5.41%3,444,926$294.99MInstitution
Nea Management Company LLC4.57%2,909,956$249.18MInstitution
Orbimed Advisors LLC4.32%2,750,079$235.49MInsider
Perceptive Advisors LLC4.01%2,548,445$218.22MInstitution
State Street Corp3.10%1,970,733$168.75MInstitution

1 of 3

RYTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RYTM87.51%12.49%Net SellingNet Buying
NUVL75.09%24.91%Net SellingNet Selling
TGTX55.59%44.41%Net SellingNet Selling
AXSM70.09%29.91%Net BuyingNet Selling
CRSP65.13%34.87%Net BuyingNet Buying
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Ownership FAQ

Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (NASDAQ: RYTM) is owned by 101.59% institutional shareholders, 14.50% Rhythm Pharmaceuticals insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Rhythm Pharmaceuticals shareholder, owning 4.36M shares representing 6.85% of the company. Ra Capital Management LP's Rhythm Pharmaceuticals shares are currently valued at $369.19M.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.